Amicus Therapeutics Inc (NASDAQ: FOLD) stock enjoyed a major increase of 14.0% on 10/17/24. The shares closed at $11.97. Moreover, exceptionally high trading volume at 431% of normal accompanied the advance. The stock has been weak relative to the market over the last nine months but has risen 17.8% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, FOLD is expected to continue to be a major Value Builder.
Amicus Therapeutics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Amicus Therapeutics has a slightly negative Power Rating of 34 and a very low Appreciation Score of 11, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment